Incidentally, if anyone cares about the various differences between vaccines:
https://www.cdc.gov.tw/En/Bulletin/Detail/SEd8rAKMzywG_b92N6z8nA?typeid=158
The Food and Drug Administration of the Ministry of Health and Welfare has approved the manufacturing of Medigen’s COVID-19 vaccine. Medigen's COVID-19 vaccine is designed for use in adults aged 20 or older, who will get two doses of the vaccine 28 days apart to build protection against COVID-19.
Explained (but not very well): What is recombinant protein vaccine? Only Novavax knows what they are doing.
Read more at:
http://timesofindia.indiatimes.com/articleshow/83740280.cms